Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 436, 468-469 (28 July 2005) | doi:10.1038/436468a; Published online 27 July 2005
Open Innovation Challenges
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
-
Methods to Analyze Consumer Emotions
The Seeker is looking for methods to analyze consumer emotions. This Challenge requires only a writ...
- More Challenges
- Powered by:
nature jobs
Materials Engineer
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
Natural Products Chemist
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
Cancer: One step at a time
David Mooney1
Abstract
Traditional chemotherapy kills tumour cells directly; some newer drugs work instead by cutting the tumour's blood supply. An innovative approach combines these strategies sequentially to pack a double whammy.
In 1971, Judah Folkman proposed that the progression of cancer might be halted by preventing tumours from recruiting new blood vessels (a process called angiogenesis) to provide them with oxygen and nutrients. Last year, this theory bore fruit with the approval by the US Food and Drug Administration of the first anti-angiogenic cancer treatment, Avastin (also known as bevacizumab)1.
- David Mooney is in the Division of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts 02138, USA.
Email: mooneyd@deas.harvard.edu
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Cancer One step at a timeNature News and Views (28 Jul 2005)
Stem cells go for the eyesNature Medicine News and Views (01 Sep 2002)
See all 5 matches for News And Views